Ching‐Shih Chen - Publications, H-index & Citations

Ching‐Shih Chen

University System of Ohio

51H指数

410论文数

8.9K被引数

收录论文 87

发表时间

Overcoming resistance to anabolic SARM therapy in experimental cancer cachexia with an HDAC inhibitor

EMBO MOLECULAR MEDICINE

IF8.3

2020-01-13

OAAI

Liva, Sophia G.; Tseng, Yu-Chou; Dauki, Anees M.; Sovic, Michael G.; Trang Vu; Henderson, Sally E.; Kuo, Yi-Chiu; Benedict, Jason A.; Zhang, Xiaoli; Remaily, Bryan C.; Kulp, Samuel K.; Campbell, Moray; Bekaii-Saab, Tanios; Phelps, Mitchell A.; Chen, Ching-Shih; Coss, Christopher C.

Papaverine and its novel derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism

CANCER RESEARCH

IF16.6

2019-07-01

PREAI

Benej, Martin; Hong, Xiangqian; Vibhute, Sandip; Scott, Sabina; Wu, Jinghai; Graves, Edward; Quynh-Thu Le; Koong, Albert C.; Giaccia, Amato J.; Chen, Ching-Shih; Yu, Bing; Papandreou, Ioanna; Denko, Nicholas C.

RETRACTION: Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent (Retraction of Vol 38, Pg 105, 2017)

CARCINOGENESIS

IF2.9

2019-04-29

OAAI

Chu, Po-Chen; Kulp, Samuel K.; Chen, Ching-Shih

RETRACTION: Corrigendum: Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent (Retraction of Vol 34, Pg 2694, 2013)

CARCINOGENESIS

IF2.9

2019-04-29

OAAI

Chu, Po-Chen; Kulp, Samuel K.; Chen, Ching-Shih

RETRACTION: Sensitizing Estrogen Receptor-negative Breast Cancer Cells to Tamoxifen with OSU-03012, a Novel Celecoxib-derived Phosphoinositide-dependent Protein Kinase-1/Akt Signaling Inhibitor (Retraction of Vol 7, Pg 800, 2008)

MOLECULAR CANCER THERAPEUTICS

IF5.5

2019-04-01

PREAI

Weng, Shu-Chuan; Kashida, Yoko; Kulp, Samuel K.; Wang, Dasheng; Brueggemeier, Robert W.; Shapiro, Charles L.; Chen, Ching-Shih

RETRACTION: Development of a Novel Class of Glucose Transporter Inhibitors (Retraction of Vol 55, Pg 3827, 2012)

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2018-05-18

OAAI

Wang, Dasheng; Chu, Po-Chen; Yang, Chia-Ning; Yan, Ribai; Chuang, Yu-Chung; Kulp, Samuel K.; Chen, Ching-Shih

RETRACTION: Development of Novel Adenosine Monophosphate-Activated Protein Kinase Activators (Retraction of Vol 53, Pg 2552, 2010)

JOURNAL OF MEDICINAL CHEMISTRY

IF6.8

2018-05-18

PREAI

Guh, Jih-Hwa; Chang, Wei-Ling; Yang, Jian; Lee, Su-Lin; Wei, Shuo; Wang, Dasheng; Kulp, Samuel K.; Chen, Ching-Shih

Targeting breast cancer stem cells by novel HDAC3-selective inhibitors 靶向乳腺癌干细胞的新型HDAC3-selective抑制剂

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

IF5.9

2017-11-01

PREAI

Hsieh, Hao-Yu; Chuang, Hsiao-Ching; Shen, Fang-Hsiu; Detroja, Kinjal; Hsin, Ling-Wei; Chen, Ching-Shih

Novel function of p21-activated kinase 3 (PAK3) in regulating Akt phosphorylation and pancreatic cancer stem cell phenotypes

CANCER RESEARCH

IF16.6

2017-07-01

PREAI

Wu, Hsing-Yu; Yang, Ming-Chen; Chu, Po-Chen; Kulp, Samuel K.; Chen, Ching-Shih

Inhibition of Jak/STAT signaling reduces the activation of pancreatic stellate cells in vitro and limits caerulein-induced chronic pancreatitis in vivo

SCIENTIFIC REPORTS

IF3.9

2017-05-11

OAAI

Komar, Hannah M.; Serpa, Gregory; Kerscher, Claire; Schwoegl, Erin; Mace, Thomas A.; Jin, Ming; Yang, Ming-Chen; Chen, Ching-Shih; Bloomston, Mark; Ostrowski, Michael C.; Hart, Phil A.; Conwell, Darwin L.; Lesinski, Gregory B.

RETRACTED: Insulin-like growth factor-I receptor is suppressed through transcriptional repression and mRNA destabilization by a novel energy restriction-mimetic agent (vol 34, pg 2694, 2013) (Retracted article. See vol. 40, 2019)

CARCINOGENESIS

IF2.9

2016-11-21

OAAI

Chu, Po-Chen; Kulp, Samuel K.; Chen, Ching-Shih

Targeting myeloid-derived suppressor cells using a novel adenosine monophosphate-activated protein kinase (AMPK) activator

ONCOIMMUNOLOGY

IF6.3

2016-07-25

OAAI

Trikha, Prashant; Plews, Robert L.; Stiff, Andrew; Gautam, Shalini; Hsu, Vincent; Abood, David; Wesolowski, Robert; Landi, Ian; Mo, Xiaokui; Phay, John; Chen, Ching-Shih; Byrd, John; Caligiuri, Michael; Tridandapani, Susheela; Carson, William

Preclinical Pharmacokinetics Study of R- and S-Enantiomers of the Histone Deacetylase Inhibitor, AR-42 (NSC 731438), in Rodents

AAPS JOURNAL

IF3.7

2016-03-04

OAAI

Cheng, Hao; Xie, Zhiliang; Jones, William P.; Wei, Xiaohui Tracey; Liu, Zhongfa; Wang, Dasheng; Kulp, Samuel K.; Wang, Jiang; Coss, Christopher C.; Chen, Ching-Shih; Marcucci, Guido; Garzon, Ramiro; Covey, Joseph M.; Phelps, Mitch A.; Chan, Kenneth K.

Integrin-linked kinase affects signaling pathways and migration in thyroid cancer cells and is a potential therapeutic target

SURGERY

IF2.7

2016-01-01

OAAI

Shirley, Lawrence A.; McCarty, Samantha; Yang, Ming-Chen; Saji, Motoyasu; Zhang, Xiaoli; Phay, John; Ringel, Matthew D.; Chen, Ching-Shih

Preclinical Investigation of the Novel Histone Deacetylase Inhibitor AR-42 in the Treatment of Cancer-Induced Cachexia 新型组蛋白去乙酰化酶抑制剂AR-42治疗癌症引起的恶病质的临床前研究

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE

IF7.2

2015-10-12

OAAI

Tseng, Yu-Chou; Kulp, Samuel K.; Lai, I-Lu; Hsu, En-Chi; He, Wei A.; Frankhouser, David E.; Yan, Pearlly S.; Mo, Xiaokui; Bloomston, Mark; Lesinski, Gregory B.; Marcucci, Guido; Guttridge, Denis C.; Bekaii-Saab, Tanios; Chen, Ching-Shih

Development of Potent Adenosine Monophosphate Activated Protein Kinase (AMPK) Activators

CHEMMEDCHEM

IF3.4

2015-09-09

OAAI

Dokla, Eman M. E.; Fang, Chun-Sheng; Lai, Po-Ting; Kulp, Samuel K.; Serya, Rabah A. T.; Ismail, Nasser S. M.; Abouzid, Khaled A. M.; Chen, Ching-Shih

ROR1 targeted delivery of OSU-2S, a non-immunosuppressive FTY720 derivative, exerts potent cytotoxicity in mantle cell lymphoma in-vitro and in-vivo

CANCER RESEARCH

IF16.6

2015-08-01

PREAI

Mani, Rajeswaran; Chiang, Chi-Ling; Frissora, Frank W.; Yan, Ribai; Mo, Xiaokui; Baskar, Sivasubramanian; Rader, Christoph; Phelps, Mitch; Chen, Ching-Shih; Lee, Robert; Byrd, John; Baiocchi, Robert; Lee, L. James; Muthusamy, Natarajan

Therapeutic targeting of KRAS mutation-driven tumor progression in colorectal cancer

CANCER RESEARCH

IF16.6

2015-08-01

PREAI

Wu, Christina; Lin, Peng-Chan; Chu, Po-Chen; Chuang, Hsiao-Ching; Kulp, Samuel; Bekaii-Saab, Tanios; Chen, Ching-Shih

Design and synthesis of novel anti-tuberculosis agents from the celecoxib pharmacophore 塞来昔布药效团新型抗结核药物的设计与合成

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2015-05-01

PREAI

Salunke, Santosh B.; Azad, Abul K.; Kapuriya, Naval P.; Balada-Llasat, Joan-Miquel; Pancholi, Preeti; Schlesinger, Larry S.; Chen, Ching-Shih